PhaseII trial of neoadjuvant chemotherapy for recurrent colorectal cancer with resectable extra hepatic metastases
Phase 2
- Conditions
- recurrent colorectal cancer with resectable extra hepatic metastases
- Registration Number
- JPRN-UMIN000006783
- Lead Sponsor
- agoya Surgical Oncology Group
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete: follow-up complete
- Sex
- All
- Target Recruitment
- 40
Inclusion Criteria
Not provided
Exclusion Criteria
1)History of drug hypersensitivity 2)Dysesthesia 3) Contraindications to using drugs 4)Multiple malignacies to be treated 5)Have hematopoietic drugs within 7days before enrollment 6)Uncontrolled body cavity fluid 7)Serious infection 8)With brain metastases 9)Significant abnormal ECG or history of cardiovascular disease 10)Serious lung disease 11)With hemorrhage 12)Uncontrolled diarrhea 13)With Intestinal paralysis, or obstruction 14)History of central nervous system disorder 15) With dementia,or severe mental disorder 16) Gravida or lactating woman 17)Not suitable for participation with any other reasons
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method